UK MHRA Full Steam Ahead On Transformation Plan But Medtech Regulation Still Held Up
UK regulatory agency’s One Agency approach on cusp of going live
Teething troubles including staffing issues and a hold-up in the progress of the post-Brexit medical devices statutory instruments have beset the UK MHRA as it transforms to a new lifecycle-based regulatory agency that puts primacy on patient safety. But there is much to celebrate, says chief executive June Raine.
